Back
Fifth Third Bancorp Vs. Travere Therapeutics, Inc. Industry Stock Comparison
Buy
72
FITB
Fifth Third Bancorp
Last Price:
$48.19
Seasonality Move:
2.02%
Buy
80
TVTX
Travere Therapeutics, Inc.
Last Price:
$40.3200
Seasonality Move:
33.23%
Buy
72
Fifth Third Bancorp (FITB)
is a Buy
Is Fifth Third Bancorp a Buy, Sell or Hold?
-
The current Fifth Third Bancorp [FITB] share price is $48.22. The Score for FITB is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
FITB is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX)
is a Buy
Is Travere Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FITB Stock Price Chart
What is Fifth Third Bancorp's stock price today?
-
The Fifth Third Bancorp share price today is $48.22Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FITB is experiencing slight selling pressure.
TVTX Stock Price Chart
What is Travere Therapeutics, Inc.'s stock price today?
-
The Travere Therapeutics, Inc. share price today is $40.2800Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.
FITB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.33 | Buy |
| Relative Strength Index (14 RSI): | 72.79 | Buy |
| Chaikin Money Flow: | 40744 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.17 - 47.91) | Buy |
| Bollinger Bands (100): | (41.97 - 46.05) | Buy |
TVTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.67 | Buy |
| Relative Strength Index (14 RSI): | 69.35 | Buy |
| Chaikin Money Flow: | 1508490 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.0318 - 36.4718) | Buy |
| Bollinger Bands (100): | (20.7309 - 34.2909) | Buy |
FITB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.9 | Buy |
| 20-day SMA: | 46.39 | Buy |
| 50-day SMA: | 43.83 | Buy |
| 200-day SMA: | 41.52 | Buy |
| 8-day EMA: | 47.8 | Buy |
| 20-day EMA: | 46.55 | Buy |
| 50-day EMA: | 44.93 | Buy |
| 200-day EMA: | 42.78 | Buy |
TVTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.7 | Buy |
| 20-day SMA: | 35.23 | Buy |
| 50-day SMA: | 33.43 | Buy |
| 200-day SMA: | 22.2 | Buy |
| 8-day EMA: | 28.52 | Buy |
| 20-day EMA: | 16.32 | Buy |
| 50-day EMA: | 7.67 | Buy |
| 200-day EMA: | 2.09 | Buy |
Fifth Third Bancorp Earnings Growth & FITB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and an increase next year of $0.49 per share.
Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.
Fifth Third Bancorp Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Travere Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||